Pervanadate elicits proliferation and mediates activation of mitogen-activated protein (MAP) kinase in the nucleus

FEBS Lett. 1997 Aug 4;412(3):420-4. doi: 10.1016/s0014-5793(97)00821-1.

Abstract

There is growing evidence for the role of protein tyrosine phosphatases in controlling such fundamental cellular processes as growth and differentiation. Pervanadate is a potent inhibitor of protein tyrosine phosphatase which has been observed here to induce proliferation in C3H10T1/2 mouse fibroblasts. Pervanadate also translocated/activated p42/44 mitogen-activated protein (MAP) kinase to the cell nucleus. An almost similar pattern of nuclear p42/44 MAP kinase stimulation is seen with TPA. On the other hand, TPA treatment results in a rapid activation of cytosolic MAP kinase which declines with time. Thus pervanadate appears as a very useful tool for studying tyrosine phosphorylation.

MeSH terms

  • Animals
  • Biological Transport
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinases / drug effects*
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Cell Division / drug effects
  • Cell Nucleus / drug effects
  • Cell Nucleus / enzymology*
  • Cells, Cultured
  • Enzyme Activation / drug effects
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology
  • Mice
  • Mice, Inbred CBA
  • Vanadates / pharmacology*

Substances

  • pervanadate
  • Vanadates
  • Calcium-Calmodulin-Dependent Protein Kinases